Aktana

Overview
News
Sales Engagement Platforms?
Product stageSegments
Growth
?
Sales Intelligence
?

Aktana specializes in providing data and intelligence solutions for life sciences industries. In October 2021, Aktana unveiled "Contextual Intelligence 360," a modular sales intelligence platform, to scale AI-driven programs that personalize the customer engagement process for life science commercial teams. Its contextual intelligence engine (CIE) uses machine learning (ML) algorithms to plan and arrange multi-channel interactions with healthcare providers (HCPs). The platform also features personalized next-best-action recommendations, customer journey mapping tools, automated workflows, a template library, and analytics and reporting. Additionally, it has native integration with customer relationship management (CRM) and marketing automation platforms (MAP) as well as an API for custom integration. By December 2022, it had served 700,000 users across 300+ brands, including over half of the top 20 pharmaceutical firms in the world, such as Pfizer, Janssen, Merck, and Novartis.

The company claimed that its solutions improved sales growth by 14% during the indication launch for an innovative oncology drug and a 10% increase in goal attainment for primary care representatives carrying multiple products.

In October 2021, The company acquired Ople.AI, a predictive analytics platform, to increase the use and adoption of AI, particularly among developing or mid-market businesses.

Key customers and partnerships

In May 2022, Spanish pharmaceutical firm Almirall announced that it would roll out the CIE solution across two well-known brands in the US. This goes further than the company's early January deployment of Aktana's technology to boost consumer interaction.

In September 2022, the company entered into a strategic partnership with Envision Pharma Group, a comprehensive global medical communications group, to provide personalized solutions that blend Envision's scientific expertise and Aktana's intelligence platform for medical affairs teams.

Funding and financials

In January 2021, the company raised USD 30 million in debt financing from Armentum Partners.

HQ location:
207 Powell Street 7th Floor San Francisco CA USA
Founded year:
2008
Employees:
251-500
IPO status:
Private
Total funding:
USD 99.2 mn
Last Funding:
USD 30.0 mn (Debt Financing; Jan 2021)
Last valuation:
USD 114.7 mn (Sep 2018)
Key competitors
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.